These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 11459778

  • 1. Mitogenic and metabolic effects of type I IGF receptor overexpression in insulin receptor-deficient hepatocytes.
    Kim JJ, Park BC, Kido Y, Accili D.
    Endocrinology; 2001 Aug; 142(8):3354-60. PubMed ID: 11459778
    [Abstract] [Full Text] [Related]

  • 2. Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes.
    Park BC, Kido Y, Accili D.
    Biochemistry; 1999 Jun 08; 38(23):7517-23. PubMed ID: 10360949
    [Abstract] [Full Text] [Related]

  • 3. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL, Blakesley VA, Koval AP, Scrimgeour AG, LeRoith D.
    Endocrinology; 1997 Jul 08; 138(7):2979-88. PubMed ID: 9202243
    [Abstract] [Full Text] [Related]

  • 4. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.
    Di Cola G, Cool MH, Accili D.
    J Clin Invest; 1997 May 15; 99(10):2538-44. PubMed ID: 9153298
    [Abstract] [Full Text] [Related]

  • 5. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
    Auclair M, Vigouroux C, Desbois-Mouthon C, Deibener J, Kaminski P, Lascols O, Cherqui G, Capeau J, Caron M.
    J Clin Endocrinol Metab; 1999 Sep 15; 84(9):3197-206. PubMed ID: 10487687
    [Abstract] [Full Text] [Related]

  • 6. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C, Arribas M, Benito M, Valverde AM.
    Endocrinology; 2003 Feb 15; 144(2):581-93. PubMed ID: 12538620
    [Abstract] [Full Text] [Related]

  • 7. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
    Scrimgeour AG, Blakesley VA, Stannard BS, LeRoith D.
    Endocrinology; 1997 Jun 15; 138(6):2552-8. PubMed ID: 9165048
    [Abstract] [Full Text] [Related]

  • 8. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
    Gonzalez-Rodriguez A, Clampit JE, Escribano O, Benito M, Rondinone CM, Valverde AM.
    Endocrinology; 2007 Feb 15; 148(2):594-608. PubMed ID: 17068137
    [Abstract] [Full Text] [Related]

  • 9. Augmented growth response to IGF-1 via increased IRS-1 in Chinese hamster ovary cells expressing kinase-negative insulin receptors.
    Inoue S, Fukuda K, Kudara T, Igura T, Inui Y, Tamura S, Hanafusa T, Kawata S, Matsuzawa Y.
    Diabetologia; 1999 Jun 15; 42(6):763-72. PubMed ID: 10382598
    [Abstract] [Full Text] [Related]

  • 10. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
    Beery R, Haimsohn M, Wertheim N, Hemi R, Nir U, Karasik A, Kanety H, Geier A.
    Endocrinology; 2001 Jul 15; 142(7):3098-107. PubMed ID: 11416032
    [Abstract] [Full Text] [Related]

  • 11. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.
    Surmacz E, Sell C, Swantek J, Kato H, Roberts CT, LeRoith D, Baserga R.
    Exp Cell Res; 1995 May 15; 218(1):370-80. PubMed ID: 7737373
    [Abstract] [Full Text] [Related]

  • 12. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
    Chen H, Yan GC, Gishizky ML.
    Cell Growth Differ; 1998 Nov 15; 9(11):939-47. PubMed ID: 9831246
    [Abstract] [Full Text] [Related]

  • 13. Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes.
    Han SI, Studer E, Gupta S, Fang Y, Qiao L, Li W, Grant S, Hylemon PB, Dent P.
    Hepatology; 2004 Feb 15; 39(2):456-63. PubMed ID: 14767998
    [Abstract] [Full Text] [Related]

  • 14. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
    Sun H, Baserga R.
    Endocrinology; 2004 Nov 15; 145(11):5332-43. PubMed ID: 15297443
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.
    Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306
    [Abstract] [Full Text] [Related]

  • 17. Phosphatidylinositol 3-kinase (PI3K) activity bound to insulin-like growth factor-I (IGF-I) receptor, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation.
    Fukushima T, Nakamura Y, Yamanaka D, Shibano T, Chida K, Minami S, Asano T, Hakuno F, Takahashi S.
    J Biol Chem; 2012 Aug 24; 287(35):29713-21. PubMed ID: 22767591
    [Abstract] [Full Text] [Related]

  • 18. IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells.
    Baudry A, Lamothe B, Bucchini D, Jami J, Montarras D, Pinset C, Joshi RL.
    FEBS Lett; 2001 Jan 19; 488(3):174-8. PubMed ID: 11163767
    [Abstract] [Full Text] [Related]

  • 19. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts CT.
    Mol Cell Biol; 2007 May 19; 27(10):3569-77. PubMed ID: 17325037
    [Abstract] [Full Text] [Related]

  • 20. Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis.
    Perrini S, Natalicchio A, Laviola L, Cignarelli A, Melchiorre M, De Stefano F, Caccioppoli C, Leonardini A, Martemucci S, Belsanti G, Miccoli S, Ciampolillo A, Corrado A, Cantatore FP, Giorgino R, Giorgino F.
    Endocrinology; 2008 Mar 19; 149(3):1302-13. PubMed ID: 18079194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.